Skip to main content
SpringerLink
Log in

Reply to the Letter to the Editor: “A “Biomarker Biopsy” for the Diagnosis of NASH: Promises from CK-18 Fragments” by Yusuf Yilmaz, Engin Ulukaya, Enver Dolar

  • Letter
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Younossi ZM, Jarrar M, Nugent C, et al. A novel diagnostic biomarker panel for obesity-related Nonalcoholic Steatohepatitis (NASH). Obes Surg. 2008.

  2. Yilmaz Y, Ulukaya E, Dolar E. A “biomarker biopsy” for the diagnosis of NASH: promises from CK-18 fragments. Obes Surg. 2008, current issue.

  3. Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44:27–33.

    Article  PubMed  CAS  Google Scholar 

  4. Yilmaz Y, Dolar E, Ulukaya E, et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007;13:837–44.

    PubMed  CAS  Google Scholar 

  5. Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis 2007;11:17–23.

    Article  PubMed  Google Scholar 

  6. Younossi Z, Gramlich T, Liu Y, Matteoni C, Pettrelli M, Goldblum J, Rybicki L, McCullough AC. Non-alcoholic fatty liver: assessment of variability in the pathologic interpretations. Mod Path 1998;11(6):560–5.

    CAS  Google Scholar 

  7. Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu Y, McCullough A. A non-alcoholic fatty liver disease: a spectrum of clinical and pathologic severity. Gastroenterology 1999;116:1413–9.

    Article  PubMed  CAS  Google Scholar 

  8. Baranova A, Younossi Z. The future is around the corner: non-invasive diagnosis of the progressive nonalcoholic steatohepatitis. Hepatology 2008;47(2):373–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA

    Ancha Baranova & Zobair M. Younossi

  2. Translational Research Institute, Inova Health System, Falls Church, VA, USA

    Ancha Baranova & Zobair M. Younossi

  3. Molecular and Microbiology Department and Center for the Study of Genomics in Liver Diseases, George Mason University, Fairfax, VA, USA

    Ancha Baranova

Authors
  1. Ancha Baranova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zobair M. Younossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zobair M. Younossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baranova, A., Younossi, Z.M. Reply to the Letter to the Editor: “A “Biomarker Biopsy” for the Diagnosis of NASH: Promises from CK-18 Fragments” by Yusuf Yilmaz, Engin Ulukaya, Enver Dolar. OBES SURG 18, 1509–1510 (2008). https://doi.org/10.1007/s11695-008-9641-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-008-9641-5

Keywords

Search

Navigation